Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Treats peptic ulcer. Sold as Robinul, Robinul Forte, Cuvposa, Seebri Neohaler, Lonhala Magnair and 3 more. Every FDA application for this active ingredient: 9 branded and 60 generic.
As of Nov 15, 2026, FDA lists 69 applications for Glycopyrrolate (sold as Robinul, Robinul Forte, Cuvposa and others), first approved Aug 11, 1961, with 3 new uses approved and 0 published complete response letters.
First approved: Aug 11, 1961
Applications: 69
New uses approved: 3
Complete response letters: 0
Medicare spending, 2025: $10.7M
Medicare Spending
CMS Part D and Part B, 2025, before manufacturer rebates; matched by generic name
Glycopyrrolate
Part D
$10.5M
+3%
59,702
Glycopyrrolate
Part B
$128K
+26364%
82,778
Cuvposa
Part D
$43K
-61%
37
Glycate
Part D
$33K
+125%
0
GLYCOPYRROLATE(J1598)
Part B
$8K
New
1,318
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
GLYCOPYRROLATE 0.2 MG/ML VIAL: $1.58 per MLGeneric · +4% in a year
GLYCOPYRROLATE 1 MG TABLET: $0.099 per unitGeneric · -8% in a year
GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION: $0.193 per MLGeneric · -14% in a year
GLYCOPYRROLATE 2 MG TABLET: $0.155 per unitGeneric · -29% in a year
CUVPOSA 1 MG/5 ML SOLUTION: $1.01 per MLBrand · 0% in a year
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA
Hikma
Sun Pharm Inds Ltd
Novartis
Fresenius Kabi USA
Aurobindo Pharma
Eugia Pharma
Alembic
Sandoz
Apotex
Accord Hlthcare
Zydus Pharms
Lupin
Abraxis Pharm